Acesion Pharma APS
Records under this name other than the patents Acesion Pharma APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 5 of 5 · Back to Acesion Pharma APS
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,048,877 | Guanidine derivatives and their medical use Lapsed on the fee record Ended Nov 1, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 1, 2023 | From the USPTO record |
| US 8,039,632 | 2-aminio-pyridine derivatives and their use as potassium channel modulators Lapsed on the fee record Ended Oct 18, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 18, 2023 | From the USPTO record |
| US 7,960,561 | 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels Lapsed on the fee record Ended Jun 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2023 | From the USPTO record |
| US 7,842,817 | 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels Lapsed on the fee record Ended Nov 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 30, 2022 | From the USPTO record |
| US 7,737,167 | 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels Lapsed on the fee record Ended Jun 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 15, 2022 | From the USPTO record |